Fluidics for Preclinical Market
Fluidics for Preclinical Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Fluidics for Preclinical Market Size and Growth
The Fluidics for Preclinical market is experiencing significant growth, driven by advancements in research technologies and increasing demand for precision in biological studies. The market size is estimated to reach USD 1.2 billion by 2025, with a compound annual growth rate (CAGR) of 8% projected from 2023 to 2025, reflecting robust development.
Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ AMETEK Inc
◍ Blacktrace Holdings Ltd
◍ Fluigent SA
◍ Halma Plc
◍ Harvard Bioscience Inc
◍ IDEX Corp
◍ IMI Plc
◍ M Dialysis AB
◍ Thermo Fisher Scientific Inc
The fluidics for the preclinical market features companies like AMETEK, Blacktrace Holdings, Fluigent, Halma, Harvard Bioscience, IDEX, IMI, M Dialysis, and Thermo Fisher. They innovate precision fluid handling, enhance laboratory automation, and improve drug development processes, driving market growth through advanced technologies and streamlined operations.
- AMETEK: $5.5 billion (2022)
- Thermo Fisher: $40 billion (2022)
- IDEX: $2.1 billion (2022)
Request Sample Report
Market Segmentation
By Application
Clinica
Research
Request Sample Report
By Product
Software and Accessories
Precision Syringe Pumps
Market Growth
Request Sample Report
$ X Billion USD
